What Happens When Big Pharma Starts Selling Mass-Market Hallucinogens
The psychedelic renaissance will resemble the 1960s, only this time, it will take place under medical authorities and state supervision, with the corporate sheen of celebrity endorsement.
Why Are Medical Authorities Playing Games With COVID Treatments?
We can no longer avoid questions about the elevation of Remdesivir and suppression of hydroxychloroquine.
White House Strikes $765 Million Deal With Kodak To Produce American-Made Drugs
Loans to Kodak will allow the United States to produce 25 percent of the ingredients needed for pharmaceutical production.
No, It’s Not Actually Cheaper To Outsource Production To China
The ‘trade benefits all countries’ school of thought that has championed trade with China is essentially flawed, since it is based on short-run considerations.
Doctors Express Hope, Questions About Using Malaria Drugs To Combat Coronavirus
In the near-term, readily available drugs azithromycin and plaquenil appear to present a limited solution to severe coronavirus cases under careful medical supervision.
Corporate Media Attacks Trump For Highlighting Potential Coronavirus Treatment
Rather than inquire about the FDA studies of anti-virals shown to have promise against coronavirus, the press proved itself yet again more interested in scoring points than in reporting.
Yes, The FDA Is In Trouble, But The New York Times’ Prescription Would Make It Worse
The FDA’s failures are a result of too much regulatory dithering and bureaucracy. Yet the Times’ prescriptions for change would just increase the dose.
Obamacare Reboots For Prescription Drugs Take Congress By Storm
American consumers deserve fair prices for our excellent health care. But lawmakers won’t deliver those prices by trying to control the market.
High-Tech Medicine Gets The Headlines, But Low-Tech Also Saves Lives
Many innovative, low-tech approaches to medicine help patients and help reduce the frequency of hospitalizations and, therefore, health care costs.
Here’s What You Need To Know About Single-Payer Health Care
Chris Jacobs joins the Federalist Radio Hour to discuss his new book, “The Case Against Single Payer: How ‘Medicare for All’ Will Wreck America’s Health Care System.”
Without Action Now, Drug-Resistant Diseases May Create Pandemics
In the United States, antimicrobial resistance causes more than 2 million infections and 23,000 deaths per year—the equivalent of a Boeing 747 crashing each week.
Why Puberty Blockers Are A Clear Danger To Children’s Health
As much as transgender ideologues disguised as doctors want to claim otherwise, some drugs pose serious and lasting risks to children.
Will Disclosing Prescription Drug Prices In TV Ads Make Any Difference?
If the ‘purpose of this regulation’ is to affect pharmaceutical pricing, then confining disclosures only to television advertisements would by definition have a limited impact.
Your Guide To The Opioid Lawsuits Aiming To Replicate The Big Tobacco Settlement
Very few lawsuits against opioid makers were brought by victims or their families. Instead, they are being filed by cities, state’s attorneys general, and even Native American tribal councils.
White House’s Reorganization Plan Would Make For A Leaner, Better FDA
The administration proposes changing the FDA’s name to the ‘Federal Drug Administration,’ making clear that its focus will solely be on drugs, devices, biologics, and tobacco.
What You Need To Know About President Trump’s Drug Pricing Plan
While such costs represent a small fraction of overall spending on health care, several dynamics help the prescription drug issue gain disproportionate attention.
How A CBO Error Could Cost The Pharmaceutical Industry Billions
A Congressional Budget Office (CBO) document released quietly on Thursday hinted at a major gaffe by the budget agency and its efforts to conceal that gaffe.
Here’s How Trump Should Address The High Cost Of Prescription Drugs
Here’s a solution: stop focusing on trying to control prescription drug prices, and start paying attention to who’s paying them.
Podcast: FDA And Scott Gottlieb On Drug Trials, Nicotine, And Opioids
Reason Reporter Mike Riggs joins Federalist Radio to share the latest news and drug policy we are seeing from the new FDA commissioner.
Is There A Big Pharma Fox In The Anti-Addiction Hen House?
A major anti-addiction nonprofit organization is getting big bucks from the pharmaceutical industry. Whose interests are the American Society of Addiction Medicine serving?
The Media Didn’t ‘Get It Wrong’ On Lafayette Park, They Lied To America — And They’re Still LyingOn June 1, 2020 and afterward, corporate media didn't scontinue reading >- Too Fat To Fly: FAA Updates Guidelines As American Obesity Crisis GrowsThe consequences of excessive weight gain have moved frcontinue reading >
- Biden’s Climate Change Stance Exposes A Delusional AdministrationIt's no wonder Biden joked to the troops, 'I keep forgecontinue reading >
